Obalon Therapeutics (San Diego, CA) a stealth mode drug startup closed on a $4.7M tranche of a $7.7M Series A financing. Participants include Domain Associates, Okapi Ventures and Phagia Technology Inc.
NextWave Pharma (Buffalo Grove, Ill) a pediatric drug company operating in stealth mode, closed $40M in Series B funding. The round was led by return investors Sofinnova Ventures and Vivo Ventures.